Zyban (Bupropion Tablets) used
Zyban (Bupropion Tablets) used originally used to treat depression is used primarily as an ant-addictive drug to treat nicotine dependence, as part of a smoking cessation programme that includes motivational support. Zyban (Bupropion Tablets) used help people who are addicted to nicotine to stop smoking, by reducing cravings and the urge to smoke as well as counteracting withdrawal symptoms, like irritability, restlessness and anxiety.
Zyban (Bupropion Tablets) work
Zyban (Bupropion Tablets) used contain bupropion which is an antidepressant that is chemically unrelated to other known antidepressant agents, although it works at the level of the brain in a way similar to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRI), which block the uptake by nerve cells of serotonin (a neurotransmitter or brain chemical that allows nerve cells to communicate). Bupropion in Zyban (Bupropion Tablets) used has minimal effect on the re-uptake of serotonin, although it is a selective inhibitor of the neuronal re-uptake of other neurotransmitters, in particular the catecholamines noradrenaline and dopamine. The anti-addictive and antidepressive properties of bupropion in Zyban (Bupropion Tablets) used are thought to be due to the same mechanism; restoring the balance of noradrenaline and dopamine in the brain, as lack of these neurotransmitters may be involved in the addiction process and may contribute to withdrawal symptoms. However, other mechanism may also be involved in helping with smoking cessation, including stimulation by bupropion of noradrenaline and dopamine receptors, increasing the effectiveness of these neurotransmitters, while at the same time blocking the action of nicotine on nicotinic acetylcholine receptor function in the brain, resulting in a reduction in the rewarding effects of nicotine, which is what contributes to nicotine addiction.
Write a reviewYour Name:
Your Review: Note: HTML is not translated!
Rating: Bad Good
Enter the code in the box below: